Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Basun

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Journal of Alzheimer'S Disease : JAD|December 21, 2012
Cerebrospinal fluid levels of heart fatty acid binding protein are elevated prodromally in Alzheimer's disease and vascular dementiaBob Olsson, Joakim Hertze, Mattias Ohlsson, et al.
Dementia and Geriatric Cognitive Disorders|May 15, 2009
Effects of omega-3 fatty acids on inflammatory markers in cerebrospinal fluid and plasma in Alzheimer's disease: the OmegAD studyYvonne Freund-Levi, Erik Hjorth, Catharina Lindberg, et al.
Journal of the American Geriatrics Society|December 5, 2008
Omega-3 fatty acid supplementation effects on weight and appetite in patients with Alzheimer's disease: the omega-3 Alzheimer's disease studyGerd Faxén Irving, Yvonne Freund-Levi, Maria Eriksdotter-Jönhagen, et al.
Neuroscience Letters|April 13, 2021
Characterization of monomeric and soluble aggregated Aβ in Down's syndrome and Alzheimer's disease brainsEleni Gkanatsiou, Charlotte Sahlin, Erik Portelius, et al.
Journal of Alzheimer'S Disease : JAD|June 18, 2014
Effects of supplementation with omega-3 fatty acids on oxidative stress and inflammation in patients with Alzheimer's disease: the OmegAD studyYvonne Freund-Levi, Inger Vedin, Erik Hjorth, et al.
Journal of Alzheimer'S Disease : JAD|March 14, 2013
Omega-3 fatty acids enhance phagocytosis of Alzheimer's disease-related amyloid-β42 by human microglia and decrease inflammatory markersErik Hjorth, Mingqin Zhu, Veronica Cortés Toro, et al.
Journal of Alzheimer'S Disease : JAD|October 9, 2010
Higher cathepsin B levels in plasma in Alzheimer's disease compared to healthy controlsJohan Sundelöf, Johan Sundström, Oskar Hansson, et al.
Journal of Alzheimer'S Disease : JAD|June 18, 2010
Cystatin C levels are positively correlated with both Abeta42 and tau levels in cerebrospinal fluid in persons with Alzheimer's disease, mild cognitive impairment, and healthy controlsJohan Sundelöf, Johan Sundström, Oskar Hansson, et al.
Journal of Alzheimer'S Disease : JAD|August 23, 2021
Effects of Peroral Omega-3 Fatty Acid Supplementation on Cerebrospinal Fluid Biomarkers in Patients with Alzheimer's Disease: A Randomized Controlled Trial-The OmegAD StudyAvin Tofiq, Henrik Zetterberg, Kaj Blennow, et al.
Archives of Neurology|February 13, 2008
Plasma beta amyloid and the risk of Alzheimer disease and dementia in elderly men: a prospective, population-based cohort studyJohan Sundelöf, Vilmantas Giedraitis, Michael C Irizarry, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Journal of Alzheimer'S Disease : JAD|December 21, 2012
Cerebrospinal fluid levels of heart fatty acid binding protein are elevated prodromally in Alzheimer's disease and vascular dementiaBob Olsson, Joakim Hertze, Mattias Ohlsson, et al.
Dementia and Geriatric Cognitive Disorders|May 15, 2009
Effects of omega-3 fatty acids on inflammatory markers in cerebrospinal fluid and plasma in Alzheimer's disease: the OmegAD studyYvonne Freund-Levi, Erik Hjorth, Catharina Lindberg, et al.
Journal of the American Geriatrics Society|December 5, 2008
Omega-3 fatty acid supplementation effects on weight and appetite in patients with Alzheimer's disease: the omega-3 Alzheimer's disease studyGerd Faxén Irving, Yvonne Freund-Levi, Maria Eriksdotter-Jönhagen, et al.
Neuroscience Letters|April 13, 2021
Characterization of monomeric and soluble aggregated Aβ in Down's syndrome and Alzheimer's disease brainsEleni Gkanatsiou, Charlotte Sahlin, Erik Portelius, et al.
Journal of Alzheimer'S Disease : JAD|June 18, 2014
Effects of supplementation with omega-3 fatty acids on oxidative stress and inflammation in patients with Alzheimer's disease: the OmegAD studyYvonne Freund-Levi, Inger Vedin, Erik Hjorth, et al.
Journal of Alzheimer'S Disease : JAD|March 14, 2013
Omega-3 fatty acids enhance phagocytosis of Alzheimer's disease-related amyloid-β42 by human microglia and decrease inflammatory markersErik Hjorth, Mingqin Zhu, Veronica Cortés Toro, et al.
Journal of Alzheimer'S Disease : JAD|October 9, 2010
Higher cathepsin B levels in plasma in Alzheimer's disease compared to healthy controlsJohan Sundelöf, Johan Sundström, Oskar Hansson, et al.
Journal of Alzheimer'S Disease : JAD|June 18, 2010
Cystatin C levels are positively correlated with both Abeta42 and tau levels in cerebrospinal fluid in persons with Alzheimer's disease, mild cognitive impairment, and healthy controlsJohan Sundelöf, Johan Sundström, Oskar Hansson, et al.
Journal of Alzheimer'S Disease : JAD|August 23, 2021
Effects of Peroral Omega-3 Fatty Acid Supplementation on Cerebrospinal Fluid Biomarkers in Patients with Alzheimer's Disease: A Randomized Controlled Trial-The OmegAD StudyAvin Tofiq, Henrik Zetterberg, Kaj Blennow, et al.
Archives of Neurology|February 13, 2008
Plasma beta amyloid and the risk of Alzheimer disease and dementia in elderly men: a prospective, population-based cohort studyJohan Sundelöf, Vilmantas Giedraitis, Michael C Irizarry, et al.
Pageof 6